PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9537519-4	1998	The guanylate cyclase inhibitor, LY-83583 (10 microM), inhibited SNP-stimulated palmitate oxidation and activation of cGMP-dependent protein kinase (PKG).	6-anilino-5,8-quinolinedione	33-41	protein kinase cGMP-dependent 1	Homo sapiens	149-152	
16390332-8	2006	Furthermore, it was observed that the inhibitory effect of Ang-(1-7) on the Na+-ATPase activity was completely reversed by 0.1 microM LY83583, an inhibitor of guanylate cyclase, and by 2 muM KT5823, a PKG (protein kinase G) inhibitor, and was mimicked by 10 nM d-cGMP (dibutyryl cGMP).	6-anilino-5,8-quinolinedione	134-141	protein kinase cGMP-dependent 1	Homo sapiens	201-204	
16390332-8	2006	Furthermore, it was observed that the inhibitory effect of Ang-(1-7) on the Na+-ATPase activity was completely reversed by 0.1 microM LY83583, an inhibitor of guanylate cyclase, and by 2 muM KT5823, a PKG (protein kinase G) inhibitor, and was mimicked by 10 nM d-cGMP (dibutyryl cGMP).	6-anilino-5,8-quinolinedione	134-141	protein kinase cGMP-dependent 1	Homo sapiens	206-222	
16390332-9	2006	Ang-(1-7) increased the PKG activity by 152% and this effect was abolished by 10 nM PD123319 and 0.1 microM LY83583.	6-anilino-5,8-quinolinedione	108-115	protein kinase cGMP-dependent 1	Homo sapiens	24-27	
23958999-5	2013	This effect was mediated by the activation of soluble guanylyl cyclase and PKG, since it was blocked by the respective enzyme inhibitors ODQ or LY83583 and KT5823, as well as by transduction with shRNA lentiviruses coding PKGII shRNA, and mimicked by the respective enzyme activators YC-1 and 8-Bromo cyclic GMP, and also by the cyclic GMP phosphodiesterase inhibitor zaprinast.	6-anilino-5,8-quinolinedione	144-151	protein kinase cGMP-dependent 1	Homo sapiens	75-78